Position in NVS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$21,964,621
-$202,153 QoQ
Shares Held
140,152
-3.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#113
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglas Lane & Associates, LLC holds $414,684,195 across 11 Drug Manufacturers - General names. NVS ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
663,667 | $168,551,507 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,556,184 | $89,667,322 | |
| 3 | MRK |
Merck & Co., Inc.
|
552,155 | $70,951,917 | |
| 4 | GSK |
GSK plc
|
946,636 | $49,622,659 | |
| 5 | NVS |
Novartis AG
This page
|
140,152 | $21,964,621 | |
| 6 | AMGN |
Amgen Inc
|
13,032 | $4,719,147 | |
| 7 | LLY |
ELI LILLY & Co
|
2,861 | $3,431,569 | |
| 8 | ABBV |
AbbVie Inc.
|
9,961 | $2,506,586 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,964,621 | 140,152 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $22,166,774 | 145,118 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $20,822,368 | 151,029 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $20,062,891 | 156,448 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $19,999,443 | 165,271 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $18,893,073 | 169,475 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $15,372,449 | 157,974 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $18,961,392 | 164,853 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $18,875,570 | 177,302 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $17,407,917 | 179,964 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $17,640,569 | 174,711 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $18,470,070 | 181,328 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $19,671,092 | 194,937 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $19,136,368 | 208,004 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $19,990,696 | 220,356 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $22,864,264 | 300,806 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $27,531,928 | 325,706 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $29,156,166 | 332,264 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $33,158,914 | 379,089 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $46,886,027 | 573,319 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $59,540,213 | 652,567 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $59,235,759 | 692,978 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $59,826,504 | 633,554 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $50,186,442 | 577,121 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $36,223,915 | 414,746 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $31,383,685 | 380,639 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||